We are live on ! Find out more
MDXH icon

MDxHealth

56 hedge funds and large institutions have $86.8M invested in MDxHealth in 2025 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

533% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 3

100% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 9

33% more funds holding

Funds holding: 4256 (+14)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

18% less capital invested

Capital invested by funds: $106M → $86.8M (-$19M)

Holders
56
Holders Change
+14
Holders Change %
+33.33%
% of All Funds
0.68%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
19
Increased
18
Reduced
9
Closed
3
Calls
Puts
Net Calls
Net Calls Change

MDXH Hedge Fund Activity: Q4 2025 in Review

56 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in MDxHealth (MDXH) for Q4 2025, worth a combined $86.8M — down 18% from $106M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new MDXH positions and 3 closed out — a net gain of 16 holders — while 18 added to existing stakes and 9 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $751K. The largest seller was EAM Investors, exiting entirely with an estimated $594K sold.

  • 56 institutional investors held MDxHealth (MDXH) as of Q4 2025, up from 42 in Q3 2025.
  • Funds reported $86.8M of MDxHealth stock for Q4 2025, down 18% quarter-over-quarter.
  • 19 funds opened new MDxHealth positions in Q4 2025 and 3 closed out, a net change of +16 holders.
  • The largest MDxHealth buyer in Q4 2025 was Susquehanna International Group, an estimated $751K added.
  • The largest MDxHealth seller in Q4 2025 was EAM Investors, an estimated $594K sold.

Based on aggregated 13F filings for Q4 2025.